{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:44:14Z","timestamp":1762659854544,"version":"build-2065373602"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.drugalcdep.2020.107845","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T11:07:38Z","timestamp":1578740858000},"page":"107845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review"],"prefix":"10.1016","volume":"208","author":[{"given":"Dimy","family":"Fluyau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelambika","family":"Revadigar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0005","first-page":"60","article-title":"Mechanisms of action of ketamine","volume":"23","author":"Adams","year":"1998","journal-title":"Anaesthesiol. Reanim."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/10550490802019543","article-title":"Dextromethorphan and quinidine combination for heroin detoxification","volume":"17","author":"Akerele","year":"2008","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0015","first-page":"142","article-title":"Amantadine as augmentation in managing opioid withdrawal with clonidine: a randomized controlled trial","volume":"9","author":"Amiri","year":"2014","journal-title":"Iran. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00213-006-0403-6","article-title":"The drugs don\u2019t work\u2014or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory","volume":"188","author":"Bannerman","year":"2006","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100739","article-title":"The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans","volume":"157","author":"Bisaga","year":"2001","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.drugalcdep.2020.107845_bib0030","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.drugalcdep.2011.05.019","article-title":"A placebo-controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence","volume":"119","author":"Bisaga","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsat.2014.01.005","article-title":"A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence","volume":"46","author":"Bisaga","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cercor\/bhq060","article-title":"NMDA receptor hypofunction in the prelimbic cortex increases sensitivity to the rewarding properties of opiates via dopaminergic and amygdalar substrates","volume":"21","author":"Bishop","year":"2010","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0045","first-page":"593","article-title":"A case of ketamine dependence","volume":"43","author":"B\u0142achut","year":"2009","journal-title":"Psychiatr. Pol."},{"issue":"13","key":"10.1016\/j.drugalcdep.2020.107845_bib0050","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1523\/JNEUROSCI.4262-04.2005","article-title":"Amantadine inhibits NMDA receptors by accelerating channel closure during channel block","volume":"25","author":"Blanpied","year":"2005","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-2999(00)00689-0","article-title":"Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists","volume":"406","author":"Blokhina","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/EJA.0000000000000877","article-title":"Low-dose ketamine infusion reduces postoperative hydromorphone requirements in opioid-tolerant patients following spinal fusion: a randomized controlled trial","volume":"36","author":"Boenigk","year":"2019","journal-title":"Eur. J. Anaesthesiol. (EJA)"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.107845_bib0065","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine: a randomized trial","volume":"63","author":"Brooks","year":"2004","journal-title":"Neurology"},{"issue":"21","key":"10.1016\/j.drugalcdep.2020.107845_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/0024-3205(91)90154-4","article-title":"Opioid receptor-coupled second messenger systems","volume":"48","author":"Childers","year":"1991","journal-title":"Life Sci."},{"issue":"2\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3940(00)01638-4","article-title":"The N-methyl-D-aspartate antagonistic and opioid components of d-methadone antinociception in the rat spinal cord","volume":"296","author":"Chizh","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma1 receptor ligands","volume":"6","author":"Cobos","year":"2008","journal-title":"Curr. Neuropharmacol."},{"year":"2013","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","key":"10.1016\/j.drugalcdep.2020.107845_bib0085"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0376-8716(02)00025-X","article-title":"A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients","volume":"67","author":"Cornish","year":"2002","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.107845_bib0095","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1360-0443.2006.01494.x","article-title":"A case of ketamine dependence with discontinuation symptoms","volume":"101","author":"Critchlow","year":"2006","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents\u2014preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0376-8716(00)00206-4","article-title":"Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials","volume":"63","author":"de los Cobos","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1472-8206.1998.tb00982.x","article-title":"Dextromethorphan and dextrorphan in rats: common antitussives\u2014different behavioural profiles","volume":"12","author":"Dematteis","year":"1998","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0304-3940(95)11364-3","article-title":"Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord","volume":"187","author":"Ebert","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0120","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0304-3959(94)90022-1","article-title":"Dextromethorphan attenuates and reverses analgesic tolerance to morphine","volume":"59","author":"Elliott","year":"1994","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1476-5381.1994.tb17127.x","article-title":"Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence","volume":"113","author":"Fundytus","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ilar.52.3.342","article-title":"Opioid dependence and NMDA receptors","volume":"52","author":"Glass","year":"2011","journal-title":"ILAR J."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.drugalcdep.2015.09.020","article-title":"Memantine improves buprenorphine\/naloxone treatment for opioid dependent young adults","volume":"156","author":"Gonzalez","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"7650","key":"10.1016\/j.drugalcdep.2020.107845_bib0140","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0145","first-page":"3","article-title":"Effect of dextromethorphan, amantadine, and ketamine on morphine withdrawal syndrome in mice","volume":"6","author":"Hajhashemi","year":"2002","journal-title":"Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-007-0998-2","article-title":"Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia","volume":"196","author":"Harris","year":"2008","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12954-017-0189-3","article-title":"Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study","volume":"14","author":"Hayashi","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0160","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Bmj"},{"issue":"7414","key":"10.1016\/j.drugalcdep.2020.107845_bib0165","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00001756-199602290-00037","article-title":"Dextromethorphan potentiates morphine antinociception but does not reverse tolerance in rats","volume":"7","author":"Hoffmann","year":"1996","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0175","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000542-200703000-00022","article-title":"Characterization of the antinociceptive and pronociceptive effects of methadone in rats","volume":"106","author":"Holtman","year":"2007","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13011-016-0087-9","article-title":"Implementation of methadone therapy for opioid use disorder in Russia\u2013a modeled cost-effectiveness analysis","volume":"12","author":"Idrisov","year":"2017","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"issue":"7\/8","key":"10.1016\/j.drugalcdep.2020.107845_bib0185","first-page":"435","article-title":"Pharmacology of methadone and its isomers","volume":"71","author":"Inturrisi","year":"2005","journal-title":"Minerva Anestesiol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5055\/jom.2011.0044","article-title":"A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts","volume":"7","author":"Jain","year":"2011","journal-title":"J. Opioid Manag."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.107845_bib0195","first-page":"625","article-title":"Effects of ketamine on precipitated opiate withdrawal","volume":"42","author":"Jovai\u0161a","year":"2006","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0376-8716(94)01063-Q","article-title":"Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants","volume":"37","author":"Kalivas","year":"1995","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2011.05.022","article-title":"Effect of glutamate receptor antagonists microinjected into the nucleus accumbens on place aversion induced by naloxone in single-dose, morphine-treated rats","volume":"666","author":"Kawasaki","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.107845_bib0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0706228","article-title":"Effect of glutamate receptor antagonists on place aversion induced by naloxone in single\u2010dose morphine\u2010treated rats","volume":"145","author":"Kawasaki","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.107845_bib0215","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00000539-200012000-00035","article-title":"The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations?","volume":"91","author":"Kissin","year":"2000","journal-title":"Anesth. Analg."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.107845_bib0220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10517-019-04430-2","article-title":"Comparative assessment of the effectiveness of noncompetitive NMDA receptor antagonists amantadine and hemantane in morphine withdrawal syndrome model","volume":"166","author":"Kolik","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"issue":"5335","key":"10.1016\/j.drugalcdep.2020.107845_bib0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0230","first-page":"147","article-title":"The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine","volume":"28","author":"Koyuncuo\u011flu","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0235","first-page":"13","article-title":"The combination of tizanidine markedly improves the treatment with dextromethorphan of heroin addicted outpatients","volume":"33","author":"Koyuncuoglu","year":"1995","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0740-5472(02)00275-1","article-title":"Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up","volume":"23","author":"Krupitsky","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"J. Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00132576-200211000-00006","article-title":"A pilot study of memantine effects on protracted withdrawal (syndrome of anhedonia) in heroin addicts","volume":"1","author":"Krupitsky","year":"2002","journal-title":"Addict. Disord. Their Treat."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0260","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1038\/srep10140","article-title":"Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.107845_bib0265","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv008","article-title":"A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment","volume":"18","author":"Lee","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0270","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1601-183X.2009.00501.x","article-title":"Heroin addiction in African Americans: a hypothesis\u2010driven association study","volume":"8","author":"Levran","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0275","first-page":"31","article-title":"Ketamine associated psychedelic effects and dependence","volume":"44","author":"Lim","year":"2003","journal-title":"Singapore Med. J."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0280","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/JCP.0000000000000144","article-title":"A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal","volume":"34","author":"Lin","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.107845_bib0285","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00023210-200923060-00002","article-title":"Prescription of heroin for the management of heroin dependence","volume":"23","author":"Lintzeris","year":"2009","journal-title":"CNS Drugs"},{"issue":"5321","key":"10.1016\/j.drugalcdep.2020.107845_bib0290","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1126\/science.276.5321.2001","article-title":"Learning mechanisms: the case for CaM-KII","volume":"276","author":"Lisman","year":"1997","journal-title":"Science"},{"issue":"546030","key":"10.1016\/j.drugalcdep.2020.107845_bib0295","first-page":"5","article-title":"The therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: a randomized clinical trial","volume":"2013","author":"Malek","year":"2013","journal-title":"ISRN Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0165-0173(99)00020-X","article-title":"NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity","volume":"30","author":"Mao","year":"1999","journal-title":"Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0305","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0310","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-8993(97)00985-2","article-title":"The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence","volume":"778","author":"McLemore","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0315","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Independent Scientific Committee on Drugs (ISCD), 2012. Ketamine use: a review","volume":"107","author":"Morgan","year":"2020","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.107845_bib0325","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1017\/S0033291707002450","article-title":"Attentional bias to incentive stimuli in frequent ketamine users","volume":"38","author":"Morgan","year":"2008","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2125.1989.tb05354.x","article-title":"Dextromethorphan: polymorphic serum pattern of the O\u2010demethylated and didemethylated metabolites in man","volume":"27","author":"Mortimer","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13556210020077091","article-title":"A putative sigma1 receptor antagonist NE\u2010100 attenuates the discriminative stimulus effects of ketamine in rats","volume":"6","author":"Narita","year":"2001","journal-title":"Addict. Biol."},{"issue":"5335","key":"10.1016\/j.drugalcdep.2020.107845_bib0340","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.278.5335.58","article-title":"Molecular and cellular basis of addiction","volume":"278","author":"Nestler","year":"1997","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.drugalcdep.2020.107845_bib0345","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"\u0394FosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0350","doi-asserted-by":"crossref","first-page":"e89985","DOI":"10.1371\/journal.pone.0089985","article-title":"Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0355","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ejp.1317","article-title":"Intraoperative S\u2010ketamine for the reduction of opioid consumption and pain one year after spine surgery: a randomized clinical trial of opioid\u2010dependent patients","volume":"23","author":"Nielsen","year":"2019","journal-title":"Eur. J. Pain"},{"issue":"1\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0360","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2004.07.017","article-title":"Opiate physical dependence and N-methyl-D-aspartate receptors","volume":"500","author":"Noda","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.107845_bib0365","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus methadone for the treatment of opioid addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.107845_bib0370","doi-asserted-by":"crossref","first-page":"a012088","DOI":"10.1101\/cshperspect.a012088","article-title":"Glutamate mechanisms underlying opiate memories","volume":"2","author":"Peters","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0375","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ana.22093","article-title":"Dextromethorphan plus ultra-low\u2010dose quinidine reduces pseudobulbar affect","volume":"68","author":"Pioro","year":"2010","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0380","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0091-3057(95)02163-9","article-title":"The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence","volume":"53","author":"Popik","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0385","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.npp.1300760","article-title":"Reinstatement of morphine-conditioned reward is blocked by memantine","volume":"31","author":"Popik","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.drugalcdep.2020.107845_bib0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0395","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.euroneuro.2011.08.002","article-title":"Evaluation of sigma (\u03c3) receptors in the antidepressant-like effects of ketamine in vitro and in vivo","volume":"22","author":"Robson","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0400","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1331\/JAPhA.2009.08091","article-title":"Dextromethorphan abuse: clinical effects and management","volume":"49","author":"Romanelli","year":"2009","journal-title":"J. Am. Pharm. Assoc."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.107845_bib0405","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(96)00249-X","article-title":"A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal","volume":"307","author":"Rosen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0410","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(92)90706-A","article-title":"Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats","volume":"221","author":"Rossetti","year":"1992","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0415","first-page":"213","article-title":"The mouse jumping test\u2013a simple screening method to estimate the physical dependence capacity of analgesics","volume":"190","author":"Saelens","year":"1971","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.107845_bib0420","first-page":"1354","article-title":"Effects of Dextromethorphan on reducing methadone dosage in opium addicts undergoing methadone maintenance therapy: a double blind randomized clinical trial","volume":"16","author":"Salehi","year":"2011","journal-title":"J. Res. Med. Sci."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0430","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004714-199508000-00005","article-title":"Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition","volume":"15","author":"Schadel","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.107845_bib0435","first-page":"493","article-title":"Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers","volume":"25","author":"Silvasti","year":"1987","journal-title":"Int. J. Clin. Pharmacol. Ther., Toxicol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.107845_bib0440","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-200401000-00022","article-title":"Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy results of a preliminary study","volume":"100","author":"Snijdelaar","year":"2004","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0445","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.phrs.2009.04.002","article-title":"Cooperative N-methyl-d-aspartate (NMDA) receptor antagonism and \u03bc-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain","volume":"60","author":"Sotgiu","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0450","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S109285291300062X","article-title":"Mechanism of action of dextromethorphan\/quinidine: comparison with ketamine","volume":"18","author":"Stahl","year":"2013","journal-title":"CNS Spectr."},{"issue":"24","key":"10.1016\/j.drugalcdep.2020.107845_bib0455","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1007\/s00213-014-3616-0","article-title":"NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling","volume":"231","author":"Tan","year":"2014","journal-title":"Psychopharmacology"},{"issue":"4989","key":"10.1016\/j.drugalcdep.2020.107845_bib0460","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.drugalcdep.2020.107845_bib0465","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(94)91538-5","article-title":"Inhibition of opiate tolerance by non-competitive Nd-aspartate receptor antagonists","volume":"633","author":"Trujillo","year":"1994","journal-title":"Brain Res."},{"issue":"2\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0470","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002130000416","article-title":"Are NMDA receptors involved in opiate-induced neural and behavioral plasticity?","volume":"151","author":"Trujillo","year":"2000","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0475","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10298420290023954","article-title":"The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity","volume":"4","author":"Trujillo","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0480","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.2741\/3596","article-title":"Mechanisms underlying morphine analgesic tolerance and dependence","volume":"14","author":"Ueda","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.drugalcdep.2020.107845_bib0485","series-title":"Pathological Pain: From Molecular to Clinical Aspects. Chichester","first-page":"155","article-title":"Anti-opioid systems in morphine tolerance and addiction-locus-specific involvement of nociceptin and the NMDA receptor","author":"Ueda","year":"2004"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.107845_bib0490","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5055\/jom.2011.0086","article-title":"Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine","volume":"7","author":"Vosburg","year":"2011","journal-title":"J. Opioid Manag."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.107845_bib0495","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/2041-210X.12708","article-title":"Open MEE: Intuitive, open\u2010source software for meta\u2010analysis in ecology and evolutionary biology","volume":"8","author":"Wallace","year":"2017","journal-title":"Methods Ecol. Evol."},{"issue":"1\u20133","key":"10.1016\/j.drugalcdep.2020.107845_bib0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2005.10.017","article-title":"Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates \u0394FosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats","volume":"527","author":"Wang","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.107845_bib0505","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/NRL.0b013e3180f60bd8","article-title":"Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action","volume":"13","author":"Werling","year":"2007","journal-title":"Neurologist"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.107845_bib0510","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/j.1552-4604.1987.tb02174.x","article-title":"The polymorphic metabolism of dextromethorphan","volume":"27","author":"Woodworth","year":"1987","journal-title":"J. Clin. Pharmacol."},{"year":"2004","series-title":"Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV\/AIDS Prevention: Position Paper","author":"World Health Organization","key":"10.1016\/j.drugalcdep.2020.107845_bib0515"},{"year":"2008","series-title":"The Methadone Fix","author":"World Health Organization","key":"10.1016\/j.drugalcdep.2020.107845_bib0520"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.107845_bib0525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0922-4106(91)90108-T","article-title":"Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain","volume":"206","author":"Zhou","year":"1991","journal-title":"Eur. J. Pharmacol. Mol. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620300107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:02:20Z","timestamp":1759827740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620300107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":105,"alternative-id":["S0376871620300107"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107845","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107845"}}